LUCD
Price
$0.94
Change
-$0.00 (-0.00%)
Updated
Nov 5, 04:00 PM (EDT)
6 days until earnings call
PAVM
Price
$1.07
Change
+$0.02 (+1.90%)
Updated
Nov 5, 04:00 PM (EDT)
Ad is loading...

LUCD vs PAVM

Header iconLUCD vs PAVM Comparison
Open Charts LUCD vs PAVMBanner chart's image
Lucid Diagnostics
Price$0.94
Change-$0.00 (-0.00%)
Volume$11.23K
CapitalizationN/A
PAVmed
Price$1.07
Change+$0.02 (+1.90%)
Volume$400
CapitalizationN/A
View a ticker or compare two or three
LUCD vs PAVM Comparison Chart
Loading...
LUCD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PAVM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
LUCD vs. PAVM commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUCD is a Buy and PAVM is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (LUCD: $0.93 vs. PAVM: $1.04)
Brand notoriety: LUCD and PAVM are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: LUCD: 54% vs. PAVM: 25%
Market capitalization -- LUCD: $42.94M vs. PAVM: $17.23M
LUCD [@Medical Specialties] is valued at $42.94M. PAVM’s [@Medical Specialties] market capitalization is $17.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.97B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUCD’s FA Score shows that 0 FA rating(s) are green whilePAVM’s FA Score has 0 green FA rating(s).

  • LUCD’s FA Score: 0 green, 5 red.
  • PAVM’s FA Score: 0 green, 5 red.
According to our system of comparison, LUCD is a better buy in the long-term than PAVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUCD’s TA Score shows that 6 TA indicator(s) are bullish while PAVM’s TA Score has 4 bullish TA indicator(s).

  • LUCD’s TA Score: 6 bullish, 4 bearish.
  • PAVM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LUCD is a better buy in the short-term than PAVM.

Price Growth

LUCD (@Medical Specialties) experienced а -3.77% price change this week, while PAVM (@Medical Specialties) price change was -6.31% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.52%. For the same industry, the average monthly price growth was -0.28%, and the average quarterly price growth was -1.52%.

Reported Earning Dates

LUCD is expected to report earnings on Mar 31, 2025.

PAVM is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Medical Specialties (+0.52% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LUCD($42.9M) has a higher market cap than PAVM($17.2M). LUCD YTD gains are higher at: -33.809 vs. PAVM (-70.335). LUCD has higher annual earnings (EBITDA): -49.75M vs. PAVM (-75.74M). PAVM (19.6M) and LUCD (18.9M) have equal amount of cash in the bank . LUCD has less debt than PAVM: LUCD (15.3M) vs PAVM (48.7M). PAVM (2.45M) and LUCD (2.43M) have equivalent revenues.
LUCDPAVMLUCD / PAVM
Capitalization42.9M17.2M249%
EBITDA-49.75M-75.74M66%
Gain YTD-33.809-70.33548%
P/E RatioN/AN/A-
Revenue2.43M2.45M99%
Total Cash18.9M19.6M96%
Total Debt15.3M48.7M31%
FUNDAMENTALS RATINGS
PAVM: Fundamental Ratings
PAVM
OUTLOOK RATING
1..100
63
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LUCDPAVM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
78%
Bullish Trend 9 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
LUCD
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PAVM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DCO59.780.55
+0.93%
Ducommun
SBRA18.670.03
+0.16%
Sabra Health Care REIT
SSTI9.83-0.09
-0.91%
SoundThinking
CELH31.07-0.41
-1.30%
Celsius Holdings
AIM0.26N/A
-1.61%
AIM ImmunoTech

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and INGN have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and INGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
+1.39%
INGN - LUCD
26%
Poorly correlated
+3.97%
PAVM - LUCD
25%
Poorly correlated
+1.27%
GENE - LUCD
25%
Poorly correlated
N/A
NNOX - LUCD
24%
Poorly correlated
-1.91%
CVRX - LUCD
24%
Poorly correlated
+12.31%
More

PAVM and

Correlation & Price change

A.I.dvisor tells us that PAVM and NNOX have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PAVM and NNOX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PAVM
1D Price
Change %
PAVM100%
+1.27%
NNOX - PAVM
26%
Poorly correlated
-1.91%
GMED - PAVM
26%
Poorly correlated
-0.21%
CVRX - PAVM
25%
Poorly correlated
+12.31%
LUCD - PAVM
25%
Poorly correlated
+1.39%
RVTY - PAVM
25%
Poorly correlated
+3.12%
More